Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-12

Clinical Trial Update: A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster [Phase 2]

View source ↗

Summary

This Phase 2 trial compares FV-100 versus valacyclovir for treatment of herpes zoster (shingles). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FV-100
  • Valacyclovir (Valacyclovir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Herpes Zoster, Shingles | Phase 2 | Status: COMPLETED